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The Rare Association of Moyamoya
Disease and Cerebral Arteriovenous
Malformations: a Case Report
A 36-year-old man was diagnosed with a right temporal lobe grade II cerebral
arteriovenous malformation (cAVM) and was treated with radiosurgery. At nine
months after the cAVM radiosurgery, the patient began to develop bilateral focal
narrowing at the M1 segments of the bilateral middle cerebral arteries. The nar-
rowing progressively deteriorated as was demonstrated on longitudinal serial fol-
low-up MR imaging. X-ray angiography performed at 51 months after radio-
surgery confirmed that the cAVM was cured and a diagnosis of moyamoya dis-
ease. To the best of our knowledge, this is the first case of cAVM-associated
moyamoya disease that developed after radiosurgery. Given the chronological
sequence of disease development and radiation dose distribution of radiosurgery,
it is proposed that humoral or unknown predisposing factors, rather than direct
radiation effects, are the cause of moyamoya disease associated with cAVM.
lthough a relatively uncommon vascular disorder, a cerebral arteriovenous
malformation (cAVM) is the major cause of hemorrhagic stroke in young
and middle-aged patients, second only to the rupture of arterial aneurysms.
A variety of cAVM related dysplastic phenomena affecting the feeding arteries and
draining veins, including flow-related aneurysms, arterial stenosis and occlusion as well
as and venous stenosis, stricture and occlusion, have been reported (1, 2). Among these
features, an association of a cAVM and moyamoya disease has been rarely observed.
Moreover, the longitudinally sequential development of a cAVM and moyamoya disease
association is also extremely rare.
Gamma-knife radiosurgery (GKRS) is an established treatment alternative for cAVM
with clearly defined benefits and risks. The risks include adverse radiation effects and a
risk of intracranial hemorrhage that develops during the latency period after GKRS (3).
We present here a case of moyamoya disease that developed after cAVM radiosurgery.
To the best of our knowledge and from a literature review, this is the first report of
cAVM-associated moyamoya disease developed after radiosurgery.
CASE REPORT
A 36-year-old man suffered from intermittent episodes of dizziness and complex visual
hallucinations for 2 3 years of irregular duration and interval. Due to a newly
developed numbness sensation over the right temporal region for one month, the patient
arrived at our hospital and asked for assistance. No loss of consciousness was found for
each attack and the patient was neurologically intact. The cerebral angiography (Fig. 1A)
showed a Spetzler grade II cAVM located at the right anterior temporal lobe that
received an arterial supply mainly from the anterior temporal branches of the right
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Amiddle cerebral artery (MCA) and the right posterior
cerebral artery (PCA) and showed early draining mainly
into the right superficial middle cerebral vein. No focal
stenosis of the intracrainal vessels was found at the initial
presentation. The patient underwent GKRS with a
maximum target dose of 31.25 Gy and a minimum dose of
17.5 Gy to the periphery of the cAVM nidus at a 56%
isodose level of the maximum target dose (average dose of
23.6 Gy). The cAVM nidus volume was estimated as 20.7
ml. The supraclinoid segment of the right internal carotid
artery and proximal MCA and anterior cerebral artery
(ACA) received as dose less than 6.25 Gy (20% isodose
level) (Figs. 1B, C). The arteries on the contra-lateral side
received far less than this radiation dose.
Continuous regression of the cAVM was observed on
serial follow-up brain MRI. Clinically the frequency of
seizure attacks decreased. However, focal narrowing at the
M1 segments of the bilateral MCA was found on follow-up
brain MR angiograms obtained at nine months and 34
months after radiosurgery (Figs. 1D, E) with progressive
deterioration. The patient suffered from near-fainting and
slurred speech at 51 months after GKRS. Acute infarcts at
the right corona radiatae were found on brain MRI. A
cerebral angiogram (Fig. 1F) confirmed cure of the right
anterior temporal cAVM and the presence of moyamoya
disease with occlusion of the bilateral supraclinoid internal
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Fig. 1. Moyamoya disease and concurrent cerebral arteriovenous malformation in 36-year-man.
A. Composite anteroposterior (AP) view of bilateral carotid angiogram shows right temporal cerebral arteriovenous malformation. 
B, C. Stereotactic MRI with dose plan show that 17.5 Gy (yellow isodose line) is prescribed to perihphery of cerebral arteriovenous
malformation nidus (magenta line). Supraclinoid segment of right internal carotid arteries and proximal middle cerebral artery received
dose of 6.25 Gy (green isodose line).
D, E. Nine months (D) and 34 months (E) after gamma-knife surgery. Time-of-flight (TOF) MR angiograms show progressive focal
stenosis at bilateral middle cerebral artery. 
F. At 51 months after gamma-knife radiosurgery, bilateral carotid angiogram confirms cure of cerebral arteriovenous malformation and
occlusion of bilateral supraclinoid internal carotid arteries, proximal middle cerebral artery and anterior cerebral artery with moyamoya
collateral vessels.
DE Fcarotid arteries (ICA), bilateral M1 segments of the MCA
and bilateral A1 segments of the ACA and collateral vessels
in the bilateral basal ganglia.
DISCUSSION
To the best of our knowledge and from a review of the
clinical literature, only 14 cases (mean age, 34 years; age
range, 11 50 years; male to female ratio 1:1) of combined
cAVM and bilateral moyamoya disease has been reported
(1, 4 9). Most of the cases (12 cases) had both neurova-
suclar anomalies at the first presentation (1, 4 7). Another
two cases had de novo development of a cAVM at a nine
years and four years follow-up of moyamoya disease (8, 9).
In two large retrospective reviews of occlusive vascular
disease associated with cAVMs, twenty cases of cAVM with
occlusion or focal stenosis of the major feeding arteries of a
cAVM were reported, respectively accounting for 3% and
1.3% in each patient group (1, 2). Nine out of the 20 cases
had a unilateral supraclinoid ICA occlusion with a variety of
moyamoya collaterals.
According to the reports mentioned above, two plausible
hypotheses were proposed to describe the pathogenesis and
relationship between an associated cAVM and moyamoya
disease. First, it was proposed that the intimal layers of
feeding arteries proliferated to accommodate the high-flow
stress that stemmed from a cAVM. The inherited protective
mechanism eventually resulted in total occlusion of the
supraclinoid ICA and the accompanying changes in
moyamoya collateral vessels (1, 7). It was also speculated
that the blood demand of brain tissue in moyamoya disease
might reactivate the pre-quiescent angiogenesis process and
finally contribute to a de novo anomalous arterio-venous
connection (8, 9). For both hypotheses, angiogenetic factors
might play an important role. One may speculate that the
radiation delivered in GKRS might induce the development
of moyamoya disease. However, as shown in Figures 1B and
C, the occluded right supraclinoid ICA, ACA and MCA
received approximately a dose of 6.25 Gy during GKRS and
the arteries in the contra-lateral side received far less than
this dose. It is reasonable to speculate that the humoral
angiogenetic factors or unknown predisposing factors from
the irradiated cAVM may have been involved in the final
development of moyamoya disease in this patient. Apart
from the two cases of acquired unilateral moyamoya
syndrome after cAVM radiosurgery that were presented at
the 1997 Annual Meeting of the Congress of Neurological
Surgeons, this is the first report of cAVM-associated
moyamoya disease that developed after radiosurgery (10).
Successful staged bypass surgery and radiosurgery for
patients with concurrent cAVM and moyamoya disease was
reported by Seol et al. (6). Our reported patient developed
moyamoya disease after cAVM GKRS. It seems simplified
that these two anomalies could be managed in two separate
stages. However, the question about which disorder should
be treated first for patients with a concurrent cAVM and
moyamoya disease might be answered by the following
hypothesis. Radiosurgery mitigates the hypoperfusion in the
adjacent brain tissues of cAVM by the steady and progressive
obliteration of cAVM nidus while avoiding the risk of sudden
interruption of the flimsy moyamoya vessels. However,
hemorrhagic events and ischemic changes in the time
window between the administration of both therapies and
before complete nidus obliteration of a cAVM are possible.
In summary, we have presented the first case of bilateral
moyamoya disease developing after cAVM radiosurgery.
Based on the chronological sequence of disease develop-
ment and the distribution of the radiation dose in
radiosurgery, it is proposed that humoral angiogenetic
factors or unknown predisposing factors, rather than direct
radiation effects, are the cause of moyamoya disease associ-
ated with a cAVM.
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